Treatment

Authors of an article explored the evolving landscape of drug safety monitoring in the context of personalized treatments, focusing on the integration of pharmacogenetics to enhance drug safety....
CURATED BY: Gary Shelton,
DNP, MSN, NP, ANP-BC, AOCNP, ACHPN

FDA Approves Amgen’s IMDELLTRA™ for Advanced Small Cell Lung Cancer

Amgen announced that the FDA has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung...
CURATED BY:
Victoria Sherry,
DNP, CRNP, ANP-BC, AOCNP

Innovative Cancer Therapies: Revolutionizing Treatment

In the past decade, significant insights into host and tumor factors promoting oncogenesis and treatment resistance have led to the...
CURATED BY:
Gary Shelton,
DNP, MSN, NP, ANP-BC, AOCNP, ACHPN

AI and Radiomics Transform Urological Cancer Care: Enhancing Personalized Diagnosis and Treatment

The integration of artificial intelligence (AI) and radiomics in managing urological cancers such as bladder, kidney, and prostate cancers represents...
CURATED BY:
Gary Shelton,
DNP, MSN, NP, ANP-BC, AOCNP, ACHPN

Pilot Study Validates Community-Based, Nurse-Led Model for Oral Cancer Treatment in Ireland

Researchers of a pilot study aimed to evaluate the feasibility of a community-based advanced nurse practitioner (ANP)-led model for managing...
CURATED BY:
Gary Shelton,
DNP, MSN, NP, ANP-BC, AOCNP, ACHPN

Advancements and Challenges in RET-Altered Cancer Treatments

The importance of the rearranged during transfection (RET) protein in cancer development has been well-established over recent decades, marking it...
CURATED BY:
Gary Shelton,
DNP, MSN, NP, ANP-BC, AOCNP, ACHPN

Global Push for Specialized Infection Surveillance in Patients With Cancer to Improve Outcomes and Safety

Patients with cancer are at increased risk of hospital-acquired bloodstream infections and central line-associated bloodstream infections, suffering from higher infection...
CURATED BY:
Gary Shelton,
DNP, MSN, NP, ANP-BC, AOCNP, ACHPN
Share